ELI LILLY & Co (LLY) stock
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3024% above fair value
$1443.50+16.22 (+1.14%)
Close on Nov 13, 2026Market cap $1.36TP/E 46.9Yield 0.43%
Eli Lilly profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Eli Lilly's profit margin for the twelve months ending Sep 30, 2026 was 31.9%. For fiscal 2025 it was 31.7%, against 23.5% the year before. The highest annual figure on record is 37.3% in fiscal 2019.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 31.7% | +8.2 |
| FY2024 | Dec 31, 2024 | 23.5% | +8.2 |
| FY2023 | Dec 31, 2023 | 15.4% | −6.5 |
| FY2022 | Dec 31, 2022 | 21.9% | +2.2 |
| FY2021 | Dec 31, 2021 | 19.7% | −5.5 |
| FY2020 | Dec 31, 2020 | 25.2% | −12.0 |
| FY2019 | Dec 31, 2019 | 37.3% | +22.2 |
| FY2018 | Dec 31, 2018 | 15.0% | +16.1 |
| FY2017 | Dec 31, 2017 | -1.0% | −13.9 |
| FY2016 | Dec 31, 2016 | 12.9% | +0.8 |
| FY2015 | Dec 31, 2015 | 12.1% | −0.1 |
| FY2014 | Dec 31, 2014 | 12.2% | −8.1 |
| FY2013 | Dec 31, 2013 | 20.3% | +2.2 |
| FY2012 | Dec 31, 2012 | 18.1% | +0.2 |
| FY2011 | Dec 31, 2011 | 17.9% | −4.1 |
| FY2010 | Dec 31, 2010 | 22.0% | +2.1 |
| FY2009 | Dec 31, 2009 | 19.8% | +30.0 |
| FY2008 | Dec 31, 2008 | -10.2% | −26.0 |
| FY2007 | Dec 31, 2007 | 15.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 26.4% | −5.3 |
| Q2 FY2026 | Jun 30, 2026 | 30.9% | −5.5 |
| Q1 FY2026 | Mar 31, 2026 | 37.4% | +15.7 |
| Q4 FY2025 | Dec 31, 2025 | 34.4% | +1.8 |
| Q3 FY2025 | Sep 30, 2025 | 31.7% | +23.2 |
| Q2 FY2025 | Jun 30, 2025 | 36.4% | +10.1 |
| Q1 FY2025 | Mar 31, 2025 | 21.7% | −3.9 |
| Q4 FY2024 | Dec 31, 2024 | 32.6% | +9.2 |
| Q3 FY2024 | Sep 30, 2024 | 8.5% | +9.1 |
| Q2 FY2024 | Jun 30, 2024 | 26.3% | +5.0 |
| Q1 FY2024 | Mar 31, 2024 | 25.6% | +6.3 |
| Q4 FY2023 | Dec 31, 2023 | 23.4% | −3.1 |
| Q3 FY2023 | Sep 30, 2023 | -0.6% | −21.5 |
| Q2 FY2023 | Jun 30, 2023 | 21.2% | +6.5 |
| Q1 FY2023 | Mar 31, 2023 | 19.3% | −5.0 |
| Q4 FY2022 | Dec 31, 2022 | 26.5% | +5.0 |
| Q3 FY2022 | Sep 30, 2022 | 20.9% | +4.5 |
| Q2 FY2022 | Jun 30, 2022 | 14.7% | −5.9 |
| Q1 FY2022 | Mar 31, 2022 | 24.4% | +4.5 |
| Q4 FY2021 | Dec 31, 2021 | 21.6% | −6.9 |
| Q3 FY2021 | Sep 30, 2021 | 16.4% | −4.7 |
| Q2 FY2021 | Jun 30, 2021 | 20.6% | −5.0 |
| Q1 FY2021 | Mar 31, 2021 | 19.9% | −4.9 |
| Q4 FY2020 | Dec 31, 2020 | 28.5% | +4.0 |
| Q3 FY2020 | Sep 30, 2020 | 21.1% | −1.8 |
| Q2 FY2020 | Jun 30, 2020 | 25.7% | +2.1 |
| Q1 FY2020 | Mar 31, 2020 | 24.9% | −58.4 |
| Q4 FY2019 | Dec 31, 2019 | 24.5% | +4.5 |
| Q3 FY2019 | Sep 30, 2019 | 22.9% | +1.2 |
| Q2 FY2019 | Jun 30, 2019 | 23.5% | +28.2 |
| Q1 FY2019 | Mar 31, 2019 | 83.3% | +58.8 |
| Q4 FY2018 | Dec 31, 2018 | 20.0% | +46.8 |
| Q3 FY2018 | Sep 30, 2018 | 21.7% | +11.8 |
| Q2 FY2018 | Jun 30, 2018 | -4.7% | −22.0 |
| Q1 FY2018 | Mar 31, 2018 | 24.5% | +26.6 |
| Q4 FY2017 | Dec 31, 2017 | -26.9% | −40.3 |
| Q3 FY2017 | Sep 30, 2017 | 9.8% | – |
| Q2 FY2017 | Jun 30, 2017 | 17.3% | – |
| Q1 FY2017 | Mar 31, 2017 | -2.1% | – |
| Q4 FY2016 | Dec 31, 2016 | 13.4% | – |
See a number that looks wrong?